Renaissance Technologies - TETRALOGIC PHARMACEUTICALS C ownership

TETRALOGIC PHARMACEUTICALS C's ticker is TLOG and the CUSIP is 88165U109. A total of 19 filers reported holding TETRALOGIC PHARMACEUTICALS C in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of TETRALOGIC PHARMACEUTICALS C
ValueSharesWeighting
Q3 2016$30,000
-50.0%
192,100
-1.5%
0.00%
Q2 2016$60,000
+66.7%
195,100
-2.7%
0.00%
Q1 2016$36,000
-21.7%
200,500
+653.8%
0.00%
Q4 2015$46,00026,6000.00%
Other shareholders
TETRALOGIC PHARMACEUTICALS C shareholders Q2 2016
NameSharesValueWeighting ↓
Clarus Ventures, LLC 4,644,705$27,357,0009.71%
First Washington CORP 194,440$1,145,0000.64%
SPHERA FUNDS MANAGEMENT LTD. 200,000$1,178,0000.29%
KINGDON CAPITAL MANAGEMENT, L.L.C. 286,801$1,669,0000.06%
EMERALD ADVISERS, LLC 175,000$1,031,0000.06%
Pine River Capital Management L.P. 209,900$1,236,0000.02%
Alyeska Investment Group, L.P. 82,943$489,0000.01%
TFS CAPITAL LLC 19,147$113,0000.01%
HighTower Advisors, LLC 66,514$392,0000.01%
DRIEHAUS CAPITAL MANAGEMENT LLC 32,143$189,0000.01%
View complete list of TETRALOGIC PHARMACEUTICALS C shareholders